dc.contributor.author | World Health Organization | en_US |
dc.coverage.spatial | Geneva | en_US |
dc.date.accessioned | 2019-07-08T09:52:55Z | |
dc.date.available | 2019-07-08T09:52:55Z | |
dc.date.issued | 2019 | |
dc.identifier.govdoc | WHO/MVP/EMP/IAU/2019.05 | |
dc.identifier.uri | https://iris.who.int/handle/10665/325773 | |
dc.description | 27 p. | en_US |
dc.language.iso | en | en_US |
dc.publisher | World Health Organization | en_US |
dc.rights | CC BY-NC-SA 3.0 IGO | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/3.0/igo | en_US |
dc.subject.mesh | Drugs, Essential | en_US |
dc.subject.mesh | Guideline | en_US |
dc.subject.mesh | Meeting Abstract | en_US |
dc.subject.mesh | Drug Utilization | en_US |
dc.title | Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines: WHO Headquarters, Geneva, 1-5 April 2019 | en_US |
dc.type | Technical documents | en_US |
dc.rights.holder | World Health Organization | en_US |